Sedation with α2 Agonist Dexmedetomidine During Unilateral Subthalamic Nucleus Deep Brain Stimulation: A Preliminary Report. [electronic resource]
- World neurosurgery May 2016
- 320-8 p. digital
Publication Type: Journal Article; Review
1878-8769
10.1016/j.wneu.2016.01.037 doi
Adrenergic alpha-2 Receptor Agonists--therapeutic use Aged Antiparkinson Agents--therapeutic use Deep Brain Stimulation--methods Dexmedetomidine--therapeutic use Female Follow-Up Studies Humans Hypnotics and Sedatives--therapeutic use Intraoperative Neurophysiological Monitoring Male Middle Aged Motor Activity--drug effects Neuropsychological Tests Parkinson Disease--physiopathology Reaction Time Retrospective Studies Severity of Illness Index Speech--drug effects Subthalamic Nucleus--drug effects Treatment Outcome